Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome
Surya K. De
Abstract
Graphical Abstract IC 50 = 11 nM (PI3Kδ); 244 nM (PI3Kα); 424 nM (PI3Kβ), 2,230 nM (PI3Kγ).
Topics & Concepts
Phosphoinositide 3-kinasePI3K/AKT/mTOR pathwayChemistryMedicineBiochemistrySignal transductionChronic Lymphocytic Leukemia ResearchPI3K/AKT/mTOR signaling in cancerImmunodeficiency and Autoimmune Disorders